The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada has become a growing reality for millions but so has the innovation and support in managing it. Let’s take a closer look at what’s shaping the Continuous Glucose Monitoring (CGM) Devices Market in the country. 🇨🇦💉
📌 Diabetes on the Rise
Over the past 10 years, the number of people living with diabetes in Canada has increased by more than 70%! 😮📈
That’s a huge jump even though fewer people are dying from diabetes-related complications, thanks to better treatment and early interventions, the number of new diagnoses keeps rising. 👨⚕️🧬
Download Sample : https://www.towardshealthcare.com/download-sample/5654
📋 Stronger Guidelines, Healthier Lives
To tackle this growing challenge, Diabetes Canada introduced updated Clinical Practice Guidelines 📚. These are designed to:
✅ Boost prevention efforts
✅ Set clear treatment standards
✅ Improve the quality of care
✅ Minimize long-term complications
💰 Big Government Support A New Device Fund!
In a major move, the Canadian federal government announced a new Device Fund in February 2024. This initiative aims to ensure that more Canadians regardless of income can access essential tools for managing diabetes.
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
🧵 The fund will help provide:
🔹 Syringes
🔹 Insulin pens and pumps
🔹 Test strips & medical supplies
🔹 Flash glucose monitors
🔹 Continuous Glucose Monitoring (CGM) devices
📦📲💊
💡 Why It Matters
CGM devices are transforming diabetes care. They offer real-time blood sugar tracking, reduce the risk of hypoglycemia, and empower individuals to take better control of their health.
🌟 With tech advancements, solid medical guidelines, and government backing, Canada’s CGM market is set for impressive growth offering hope, support, and better outcomes for people living with diabetes.
Request a customized case study tailored to your business needs and gain deeper insights into healthcare market strategies: sales@towardshealthcare.com
The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global… Read More
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! 👇 👵👴 An… Read More
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for malignant melanoma, a… Read More